JeanMarie Guenot is a prosperous woman who has used her medical experience to help so many people. She is well known in the building and rebuilding of health facilities. 20 years is the umber of years she has been in the medical business, therefore she is an accomplished doctor who deserves her title. She achieved a Ph.D from the University of California and an MBA from the University of Pennsylvania in the Wharton School. Her specific fields in the medical industry are pharmaceutical ad biotechnology.
SKS Ocular and SKS Ocular 1 are one of the first organizations she began managing. These companies were in charge of distributing medicine initiatives, incessant release ocular medicine and dry AMD. She had the role of vice president at PDL BioPhama where she handled corporate and business growth. After sometime JeanMarie Guenot was the company advisor of Hoffmann-La Roche and Shanghai in Basel. She handled the Biogen Idec, it had 3 areas of Phase 2 Cancer and autoimmune illness patients.
In 2005, she attained an award in Bio Business Network Initiative due to her excellent work. In a nutshell, she was also a businesswoman. She participated in the PDL’s manufacturing and profitable trades. Furthermore, Guenot was a member of the administrative Committee of PDL and also an associate at the executive Team. Among other fields of diseases where she contributes in eradicating are; autoimmune diseases, neurology and oncology.
Currently JeanMarie Guenot and her associates lead Amphivena Therapeutics. This firm is located in San Francisco in California. The company was started with the aim of eradicating different forms of blood cancers, cancer is a killer disease, and the firm hopes to abolish it and handing a normal life to people suffering from it. In order of abolishing the cancer cells, the company has particular modified therapy that brings together the immune system of the patients.
The firm hopes that it will achieve more in this therapy and apparently they have created an antibody treatment that will help in detecting cancer symptoms and signs. The organization has also received help and medical support from different medical professionals in various facilities in the aim of abolishing cancer cells. Read more about Amphivena’s latest partnership on Takeda’s website: https://www.takeda.com/news/2017/20170111_7659.html